Cannabis abuse and the course of recent-onset schizophrenic disorders.

No abstract is available for this paper.

• Publication year

  1994

• Venue

  Archives of General Psychiatry

• Publication date

  1994-04-01

• Fields of study

  Biology, Medicine, Psychology

• Identifiers
  DOI 10.1016/1353-1131(95)90097-7PMID 8161287
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Influence of cannabis abuse on schizophrenic psychopathology

  1992cited by this paper
• Substance abuse and schizophrenia: effect on symptoms but not on neurocognitive function.

  1991cited by this paper
• Relationship between the Brief Psychiatric Rating Scale and the Scale for the Assessment of Negative Symptoms: a study of their correlation and redundancy.

  1991cited by this paper
• National Institute of Mental Health longitudinal study of chronic schizophrenia. Prognosis and predictors of outcome.

  1991cited by this paper
• Marijuana's interaction with brain reward systems: update 1991.

  1991cited by this paper
• Drug abuse in schizophrenic patients: clinical correlates and reasons for use.

  1991cited by this paper
• Cannabis and Psychosis

  1990cited by this paper
• Substance abuse and schizophrenia: Effects on symptoms but not on neurocognitive function

  1990cited by this paper
• Validation of self-reported cannabis use by urine analysis.

  1988cited by this paper
• BMPD statistical software manual

  1988cited by this paper
• Validation of self-reported cannabis use by urine analysis

  1988cited by this paper
• Cannabis and schizophrenia. A longitudinal study of Swedish conscripts.

  1987cited by this paper
• Rating scales in research: the case of negative symptoms.

  1987cited by this paper
• A Review of Psychoactive Substance Use and Abuse in Schizophrenia: Patterns of Drug Choice

  1987cited by this paper
• Pathology, Phenomenology and the Dopamine Hypothesis of Schizophrenia

  1987cited by this paper
• Cannabis affects the severity of schizophrenic symptoms: results of a clinical survey

  1986cited by this paper
• Expressed emotion, fixed-dose fluphenazine decanoate maintenance, and relapse in recent-onset schizophrenia.

  1986cited by this paper
• Cannabis and neuroleptic agents in schizophrenia

  1984cited by this paper
• Cannabis-associated psychosis with hypomanic features.

  1982cited by this paper
• Marijuana use in schizophrenia: a clear hazard.

  1978cited by this paper
• Part II. Measuring Premorbid Adjustment: The Instruments and Their Development*

  1977cited by this paper
• Prediction of outcome in schizophrenia. III. Five-year outcome and its predictors.

  1977cited by this paper
• Premorbid adjustment in schizophrenia. Part II. Measuring premorbid adjustment: the instruments and their development.

  1977cited by this paper
• Psychotic reactions following cannabis use in East Indians.

  1974cited by this paper
• Adverse reactions to marihuana. Classification and suggested treatment.

  1970cited by this paper
• Social Class and Mental Illness

  1964cited by this paper
• The Brief Psychiatric Rating Scale

  1962cited by this paper

• Cessation of cannabis use by patients with recent-onset schizophrenia and related disorders.

  2025cites this paper
• Differences in efficacy on substance abuse between risperidone and clozapine supports the importance of differential modulation of dopaminergic neurotransmission.

  2025cites this paper
• Exposotypes in psychotic disorders

  2025cites this paper
• International perspectives on physician knowledge, attitudes, and practices related to medical cannabis

  2025cites this paper
• Recent-onset schizophrenia and adolescent cannabis use: MRI evidence for structural hyperconnectivity?

  2025cites this paper
• Naturalistic outcomes of patients discharged from a community treatment order: QA project

  2024cites this paper
• Lower levels of cortical [3H]pirenzepine binding to postmortem tissue defines a sub-group of older people with schizophrenia with less severe cognitive deficits.

  2023cites this paper
• Cannabis use during the early COVID-19 pandemic: Use patterns, predictors, and subjective experiences

  2023cites this paper
• Cannabis Use and Symptomatic Relapse in First Episode Schizophrenia: Trigger or Consequence? Data From the OPTIMISE Study.

  2023cites this paper
• International perspective on physician knowledge, attitude and practices related to medical cannabis

  2023cites this paper
• Does a history of cannabis use influence onset and course of schizophrenia?

  2023cites this paper
• Examining the Use of Antidepressants for Adolescents with Depression/Anxiety Who Regularly Use Cannabis: A Narrative Review

  2022cites this paper
• Gut–microbiota–brain axis in the vulnerability to psychosis in adulthood after repeated cannabis exposure during adolescence

  2022cites this paper
• It might be a wonderful opportunity when patients with a psychotic disorder use cannabis

  2022cites this paper
• Cannabis sativa L. Bioactive Compounds and Their Protective Role in Oxidative Stress and Inflammation

  2022cites this paper
• Atypical antipsychotics in the treatment of patients with a dual diagnosis of schizophrenia spectrum disorders and substance use disorders: the results of a randomized comparative study

  2021cites this paper
• A systematic review of longitudinal studies investigating the impact of cannabis use in patients with psychotic disorders

  2021cites this paper
• The effects of nabilone and dexamphetamine on three underlying schizotypy dimensions of delusions/hallucinations, mania and delusional guilt

  2021cites this paper
• Cannabis Use, Schizotypy and Kamin Blocking Performance

  2021cites this paper
• The Importance of Suicide Risk Formulation in Schizophrenia

  2021cites this paper
• Differential effects of Δ9-tetrahydrocannabinol dosing on correlates of schizophrenia in the sub-chronic PCP rat model

  2020cites this paper
• Determining factors for Cannabis use among Moroccans Schizophrenic Patients: A cross sectional study

  2020cites this paper
• Modern approaches to the diagnosis and care of patients at the prodromal stage of schizophrenia

  2020cites this paper
• Concurrent

  2020cites this paper
• Research Online Research Online Cannabis-induced psychosis-like experiences are associated with high Cannabis-induced psychosis-like experiences are associated with high schizotypy schizotypy

  2020cites this paper
• The impact of sex and cannabis on clinical features in first-admitted patients with psychosis.

  2020cites this paper
• Aripiprazole Long-Acting Injection During First Episode Schizophrenia—An Exploratory Analysis

  2020cites this paper
• Measuring individual benefits of psychiatric treatment using longitudinal binary outcomes: Application to antipsychotic benefits in non-cannabis and cannabis users

  2020cites this paper
• Facilitators and Barriers to Participating in a Randomized Controlled Trial of a Psychological Therapy for Substance Use.

  2019cites this paper
• Models of Concurrent Disorder Service: Policy, Coordination, and Access to Care

  2019cites this paper
• Caring for Patients Using Medical Marijuana

  2019cites this paper
• Cannabidiol Improves Cognitive Impairment and Reverses Cortical Transcriptional Changes Induced by Ketamine, in Schizophrenia-Like Model in Rats

  2019cites this paper
• Ventral hippocampal overexpression of Cannabinoid Receptor Interacting Protein 1 (CNRIP1) produces a schizophrenia-like phenotype in the rat.

  2019cites this paper
• Mobile Intervention for Individuals With Psychosis, Dual Disorders, and Their Common Comorbidities: A Literature Review

  2019cites this paper
• Increased BDNF‐TrkB signaling in the nucleus accumbens plays a role in the risk for psychosis after cannabis exposure during adolescence

  2019cites this paper
• Factor structure of the Cannabis Experiences Questionnaire in a first‐episode psychosis sample

  2019cites this paper
• [Aripiprazole and quetiapine in the treatment of patients with 'dual diagnosis' of schizophrenia and drug addiction].

  2019cites this paper
• Changes in Connectivity between Caudate and Frontal Lobe in Patient with Psychosis Induced for Cannabis - Case Report

  2019cites this paper
• A contingency management intervention to reduce cannabis use and time to relapse in early psychosis: the CIRCLE RCT.

  2019cites this paper
• Cannabis und Schizophrenie – Risikofaktoren, diagnostische Einordnung und Auswirkungen auf Verlauf und Prognose

  2019cites this paper
• Molecular neuroscience at its “high”: bibliometric analysis of the most cited papers on endocannabinoid system, cannabis and cannabinoids

  2019cites this paper
• Liječenje rezistentne shizofrenije

  2019cites this paper
• Les liens de causalité entre la consommation de cannabis et la schizophrénie

  2019cites this paper
• An Investigation into Caffeine Intake, Cognition, and Symptomatology in Schizophrenia Patients

  2019cites this paper
• Clinical and cost-effectiveness of contingency management for cannabis use in early psychosis: the CIRCLE randomised clinical trial

  2019cites this paper
• The Cardiovascular Effects of Marijuana: Are the Potential Adverse Effects Worth the High?

  2019cites this paper
• Medication adherence in first episode psychosis: the role of pre‐onset subthreshold symptoms

  2019cites this paper
• Evidence-based guidelines for the pharmacological treatment of schizophrenia: Updated recommendations from the British Association for Psychopharmacology

  2019cites this paper
• Is Cannabis Harmless? Focus on Brain Function.

  2019cites this paper
• Investigating the potential cognitive-behavioural mechanism of change underlying abstinence from cannabis use amongst young people with a history of psychosis and problematic cannabis use

  2019influential citation
• University Students’ Perceptions of Links Between Substance Use and Mental Health

  2018cites this paper
• Appendix C: References (Part I)

  2018cites this paper
• Cannabis Use Disorders

  2018cites this paper
• Part I: Current Legislation, Scientific Literature Review, and Nursing Implications

  2018cites this paper
• Adolescent Synthetic Cannabinoid Exposure Produces Enduring Changes in Dopamine Neuron Activity in a Rodent Model of Schizophrenia Susceptibility

  2018cites this paper
• Longitudinal assessment of the effect of cannabis use on hospital readmission rates in early psychosis: A 6-year follow-up in an inpatient cohort.

  2018cites this paper
• Endocannabinoid signaling in psychiatric disorders: a review of positron emission tomography studies

  2018cites this paper
• The Association Between Cannabinoids and Psychosis

  2018cites this paper
• Evaluation of a substance use treatment program for forensic psychiatric inpatients

  2018cites this paper
• Unique Effects of Clozapine: A Pharmacological Perspective.

  2018cites this paper
• Prevalence of comorbid substance use in schizophrenia spectrum disorders in community and clinical settings, 1990-2017: Systematic review and meta-analysis.

  2018cites this paper
• Meta-analysis of neurocognition in young psychosis patients with current cannabis use.

  2018cites this paper
• The Potential of Cannabidiol Treatment for Cannabis Users With Recent-Onset Psychosis.

  2018cites this paper
• Impact of Chronic Cannabis Use on Auditory Mismatch Negativity Generation in Schizophrenia Patients

  2018cites this paper
• The Measurement of Substance Use in Forensic Schizophrenia Spectrum Disorders-Initial Validation of a New Scale

  2018cites this paper
• Cannabis and Brain: Disrupting Neural Circuits of Memory

  2018cites this paper
• Clinical and functional outcomes of cannabis use among individuals with anxiety disorders: A 3‐year population‐based longitudinal study

  2018cites this paper
• Reduced type III neuregulin 1 expression does not modulate the behavioural sensitivity of mice to acute &Dgr;9‐tetrahydrocannabinol (D9‐THC)

  2018cites this paper
• PREMORBID ADJUSTMENT AND CANNABIS USE IN FIRST-EPISODE-PSYCHOSIS PATIENTS. A CROSS-EUROPEAN CASE-CONTROL STUDY

  2017cites this paper
• Differential effects of cannabis dependence on cortical inhibition in patients with schizophrenia and non-psychiatric controls.

  2017cites this paper
• Cannabis: A Treasure Trove or Pandora's Box?

  2017cites this paper
• The Effect of Substance Use on 10-Year Outcome in First-Episode Psychosis

  2017cites this paper
• Place du concept d’émotion exprimée dans les conduites addictives

  2017cites this paper
• Specific impact of stimulant, alcohol and cannabis use disorders on first-episode psychosis: 2-year functional and symptomatic outcomes

  2017influential citation
• Cannabis use and the course and outcome of major depressive disorder: A population based longitudinal study.

  2017cites this paper
• Long lasting effects of chronic heavy cannabis abuse

  2017cites this paper
• Title : Cannabis use and adherence to antipsychotic medication : a systematic review and meta-analysis

  2017influential citation
• Is there a common vulnerability in cannabis phenomenology and schizotypy? The role of the N170 ERP.

  2017cites this paper
• Cannabis use and adherence to antipsychotic medication: a systematic review and meta-analysis

  2017influential citation
• Neurobiology of Comorbid Substance Use Disorders and Psychiatric Disorders: Current State of Evidence

  2017cites this paper
• Addiction and schizophrenia: A translational perspective.

  2017cites this paper
• The Endocannabinoid System in Prefrontal Synaptopathies

  2017cites this paper
• The link between schizophrenia and substance use disorder: A unifying hypothesis.

  2017cites this paper
• The Use of Medical Marijuana in the Treatment of Psychiatric Disorders

  2017cites this paper
• Personality in patients with dual diagnosis: The influence of severe mental illness

  2017cites this paper
• Changes in the Connectivity between the Caudate Nucleus and the Frontal Lobe in a Patient with Cannabis Induced Psychosis

  2017cites this paper
• The Endocannabinoid System and Human Brain Functions: Insight From Memory, Motor, and Mood Pathologies

  2017cites this paper
• What Have We Learned From the Agonist Opioid Treatment of Dual Disorder Heroin Addicts?

  2017cites this paper
• Interactions between cannabis and schizophrenia in humans and rodents

  2017cites this paper
• Clozapine Treatment and Cannabis Use in Adolescents with Psychotic Disorders - A Retrospective Cohort Chart Review.

  2017cites this paper
• Review: Cannabis use increases the risk of psychotic outcomes

  2017cites this paper
• Lifetime Cannabis Use and Cognition in Psychosis Spectrum Disorders

  2017cites this paper
• Using Claims Data to Examine Hospital Readmission Risk in Patients With Schizophrenia and Comorbid Marijuana Use Disorders.

  2017cites this paper
• Continued versus discontinued cannabis use in patients with psychosis: a systematic review and meta-analysis.

  2016cites this paper
• A Study of the Impact of Cannabis on Doses of Discharge Antipsychotic Medication in Individuals with Schizophrenia or Schizoaffective Disorder

  2016cites this paper
• Cannabis use related to early psychotic onset: Role of premorbid function.

  2016cites this paper
• Characterizing the Effects of Extended Cannabis Abstinence on Cognitive Function in Patients with Schizophrenia and Non-psychiatric Controls with Cannabis Dependence

  2016cites this paper
• A randomised controlled trial of the clinical and cost-effectiveness of a contingency management intervention compared to treatment as usual for reduction of cannabis use and of relapse in early psychosis (CIRCLE): a study protocol for a randomised controlled trial

  2016cites this paper
• Efectos del cannabis sobre la salud mental en jóvenes consumidores

  2016cites this paper
• Building therapeutic relationship in schizophrenic and alcohol-related disorder cases

  2016cites this paper